ranimustine has been researched along with Leukemia, Myeloid in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (75.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, N; Fujita, S; Fujitake, H; Harashima, S; Hirata, M; Hirota, Y; Horiuchi, A; Hoshino, A; Kamiya, O; Kanamaru, R; Kanayama, Y; Katoh, Y; Kawagoe, H; Kimura, K; Kitani, T; Kojima, T; Konda, C; Masaoka, T; Matsubuchi, T; Miyazaki, T; Morioka, M; Musashi, M; Nagai, K; Nagata, K; Nakamura, T; Nakao, I; Oguro, M; Ohara, K; Ohhashi, Y; Ohkubo, A; Ohno, R; Okamoto, Y; Saitoh, H; Saitoh, T; Sakai, Y; Sakurada, K; Sasada, M; Sasaki, T; Shibata, H; Takada, T; Takagi, T; Takubo, T; Taniguchi, N; Tsubaki, K; Tsubakio, T; Wakui, A; Yamada, K; Yasunaga, K; Yokoyama, M; Yonezawa, T | 1 |
| Murase, T; Nagura, E; Ohno, R | 1 |
| Ashihara, E; Fujita, N; Goto, H; Hirata, T; Inaba, T; Nakagawa, M; Okawa, K; Oku, N; Shimazaki, C; Yamagata, N | 1 |
| Bandoh, S; Fujita, M; Funamoto, Y; Kuwabara, H; Nagai, M; Takahara, J; Tasaka, T; Yamaoka, G; Yamauchi, A | 1 |
| Hirose, Y; Masaki, Y; Sugai, S | 1 |
| Hiraoka, A; Horiuchi, A; Kawagoe, H; Kitani, T; Masaoka, T; Miyazaki, T; Nakamura, T; Shibata, H; Yasunaga, K; Yonezawa, T | 1 |
| Hirata, M; Horiuchi, A; Kanamaru, A; Kawagoe, H; Kitani, T; Masaoka, T; Nagai, K; Shibata, H; Taniguchi, N; Tsubaki, K | 1 |
| Kobayashi, M; Sugiura, I; Yamada, K | 1 |
| Ikeda, Y; Kobayashi, M; Kobayashi, T; Ohno, R; Ohta, K; Shirakawa, S; Tanaka, I; Yamada, H; Yamada, K; Yamagata, K | 1 |
| Higuchi, A; Imamura, M; Kasai, M; Maekawa, I; Miyazaki, T; Morioka, M; Musashi, M; Ohtani, N; Saitoh, H; Sakurada, K | 1 |
| Ando, S; Domae, N; Hashimoto, E; Kagawa, D; Nakamura, T; Sasada, M; Tsutani, H; Uchida, M; Uchino, H; Ueda, T | 1 |
| Fujitake, H; Hirota, Y; Kimura, K; Kitani, T; Masaoka, T; Miyazaki, T; Nakamura, T; Ohkubo, H; Okamoto, Y; Yasunaga, K | 1 |
3 trial(s) available for ranimustine and Leukemia, Myeloid
| Article | Year |
|---|---|
[Phase II study with methyl-6[[[2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Multiple Myeloma; Nitrosourea Compounds | 1983 |
A new nitrosourea derivative for the treatment of chronic myelogenous leukemia.
Topics: Adult; Aged; Antineoplastic Agents; Busulfan; Clinical Trials as Topic; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Nitrosourea Compounds; Random Allocation; Remission Induction | 1988 |
[Randomized controlled study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in comparison with busulfan for chronic myelogenous leukemia].
Topics: Adult; Aged; Antineoplastic Agents; Busulfan; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Nitrosourea Compounds; Random Allocation | 1985 |
9 other study(ies) available for ranimustine and Leukemia, Myeloid
| Article | Year |
|---|---|
[Prolonged remission in a patient with chronic myelocytic leukemia (CML) by methyl 6-[3-(2-chloroethyl)-3-deoxy-alpha-D-glucopyranoside (MCNU)].
Topics: Adult; Alkaline Phosphatase; Antineoplastic Agents; Chromosomes, Human, 21-22 and Y; Female; Humans; Leukemia, Myeloid; Nitrosourea Compounds | 1984 |
Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis.
Topics: Acute Disease; Adolescent; Adult; Blood Component Transfusion; Busulfan; Combined Modality Therapy; Etoposide; Female; Flow Cytometry; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Leukemia, Myeloid; Leukocyte Count; Leukopenia; Lymphocyte Subsets; Lymphoma; Male; Middle Aged; Nitrosourea Compounds; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1994 |
Secondary myeloid/natural killer cell precursor acute leukemia following essential thrombocythemia.
Topics: Antigens, CD; Cell Transformation, Neoplastic; Humans; Immunophenotyping; Killer Cells, Natural; Leukemia, Myeloid; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Thrombocythemia, Essential | 1999 |
Leukemic transformation with trisomy 8 in essential thrombocythemia: a report of four cases.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Busulfan; Cell Transformation, Neoplastic; Chromosomes, Human, Pair 8; Disease Progression; Female; Humans; Hydroxyurea; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Nitrosourea Compounds; Thrombocythemia, Essential; Trisomy | 2002 |
[Phase II study on oral administration of MCNU (ranomustine) tablet. Hanshin Cooperative Study Group on Hematological Disorders].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Leukemia, Myeloid; Male; Middle Aged; Nitrosourea Compounds; Polycythemia; Tablets; Thrombocytosis | 1986 |
[Prolonged disappearance of the Ph1 chromosome in a case of chronic myelogenous leukemia after administration of MCNU].
Topics: Aged; Antineoplastic Agents; Humans; Leukemia, Myeloid; Male; Nitrosourea Compounds; Philadelphia Chromosome | 1987 |
[Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Child; Drug Evaluation; Female; Hematologic Diseases; Humans; Leukemia; Leukemia, Myeloid; Lung Neoplasms; Lymphoma; Male; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Polycythemia Vera; Stomach Neoplasms; Thrombocytopenia | 1985 |
[Phase II study with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
Topics: Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia, Myeloid; Lymphoma; Male; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Polycythemia | 1985 |
[Action mechanism of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in leukemic cells].
Topics: Animals; Antineoplastic Agents; Cell Division; DNA; DNA Repair; Humans; Leukemia, Myeloid; Mice; Mice, Inbred Strains; Nitrosourea Compounds | 1985 |